Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joshua Frank

Sports Medicine Norwalk, CT Medical Doctor

NPI 1598898843 CMS profile 27183

761 Main Ave, Suite 115, Norwalk, CT 06851

Open in the dashboard

General payments

$77,970

94 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joshua Frank of Norwalk, CT is reported in the CMS Open Payments database as having received $77,970 across 94 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $497 11
2024 General $364 5
2023 General $486 9
2022 General $3,187 36
2021 General $22,662 8
2020 General $22,693 6
2019 General $28,082 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Frank
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Joshua Frank were reported at $497. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Joshua Frank Sports Medicine median Middle half National median
2019 $28,082 $1,176 $199–$4,249 $163
2020 $22,693 $708 $96–$2,890 $114
2021 $22,662 $1,213 $152–$3,994 $132
2022 $3,187 $1,230 $159–$3,998 $149
2023 $486 $584 $146–$2,836 $160
2024 $364 $628 $163–$3,168 $164
2025 $497 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Products, Inc. $72,199 12 payments
  2. Gotham Surgical Solutions & Devices, Inc. $1,337 4 payments
  3. Arthrex, Inc. $1,254 20 payments
  4. DePuy Synthes Sales Inc. $895 21 payments
  5. Vericel Corporation $711 6 payments
  6. Stryker Corporation $463 9 payments
  7. Polaris Technology Solutions LLC $365 3 payments
  8. Smith+Nephew, Inc. $249 5 payments
  9. Bioventus LLC $165 7 payments
  10. Flexion Therapeutics, Inc. $123 1 payment
  11. Other $207 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $72,199 12 payments
  2. Food and Beverage $3,185 76 payments
  3. Education $1,200 1 payment
  4. Travel and Lodging $836 4 payments
  5. Honoraria $550 1 payment
Products named General payments · program years 2019–2025
  1. GRYPHON $50,119 9 payments
  2. Gryphon Orthocord $22,206 5 payments
  3. MACI Cellular Therapy $562 2 payments
  4. HEALIX KNOTLESS PEEK $411 5 payments
  5. FMS $360 8 payments
  6. VAPR $317 6 payments
  7. HEALIX $227 6 payments
  8. MACI Orthopedics $150 4 payments
  9. AXSOS $141 3 payments
  10. MOTIONSENSE DIGITAL GONIOMETER $133 1 payment
  11. Other $2,246 50 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

426

Median for Orthopedic Surgery: 203

Drug cost

$1,929

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 226 $668
Methylprednisolone Generic 91 $655
Celecoxib Generic 16 $224
Prednisone Generic 49 $185
Cyclobenzaprine Hcl Generic 17 $104
Ondansetron Hcl Generic 27 $93

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$212,743

Of which drugs: $56,826

Medicare patients

468

Average age 77

Services billed

12,069

310 women, 158 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Ischemic heart disease 26%
Osteoporosis 25%
Depression 22%
Cancer 21%
Atrial fibrillation 19%
Diabetes 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg J7329 Office 77 8,225 $45,665
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 175 941 $5,188
Injection, ketorolac tromethamine, per 15 mg J1885 Office 11 48 $28

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

94 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record